Pharma firm opens Irish base creating 100 jobs to ensure access to single market post Brexit
Up to 100 jobs are being created in Dundalk as a Northern Ireland-headquartered health-care manufacturer boosts its European presence.
The development is regarded by the State as a Brexit-related win.
Almac Group, a global contract pharmaceutical development and manufacturing organisation, has its global and European headquarters in Craigavon but is opening the new facility in Co Louth as part of a global expansion.
It is understood the Craigavon facility is not being affected by the move.
It said the new facility would provide the company with “continued presence within the European Union in the long term”. It already has a facility in Athlone.
IDA chief executive Martin Shanahan said the development certainty of access to the EU.
“Almac’s decision to expand into Dundalk provides the company with certainty of access to the European Union in the long term– this certainty of access is an increasingly important selling point for Ireland as we look to win business for Ireland,” Mr Shanahan said.
“IDA Ireland will continue to promote Ireland as an ideal location for companies from a range of sectors including pharmaceuticals, IT and financial services that are looking to ensure that they have a presence in the European single market.”
Alan Armstrong, Almac Group chief executive, said the 100 jobs will be rolled out within the first two years.
“This news comes in addition to our recent announcement of a £27m investment at our global Headquarter site in Craigavon, our US operations and our European facility in Athlone,” he said.